THU0118 TREATMENT OF RHEUMATOID ARTHRITIS WITH COMBINATION THERAPY USING A BIOLOGIC AGENT AND METHOTREXATE LOWERS THE RISK OF DECREASING KIDNEY FUNCTION COMPARED TO METHOTREXATE MONOTHERAPY release_rev_52453e0d-e599-46eb-a09b-bd21eab4de37

by MIWA YUSUKE, Nobuyuki Yajima, Sakiko Isojima, Ryo Yanai, Mika Hatano, Yoko Miura, Nao Oguro, Tomoki Hayashi, Kosuke Sakurai, Tsuyoshi Kasama

Released as a paper-conference by BMJ Publishing Group Ltd and European League Against Rheumatism
Release Year 2019
Publisher BMJ Publishing Group Ltd and European League Against Rheumatism
Type  paper-conference
Stage   unknown
Year   2019
Work Entity
grouping other versions (eg, pre-print) and variants of this release
Revision

This is a specific, static metadata record, not necessarily linked to any current entity in the catalog.